Keywords: maze, study, shows, inadequate, use, migraine-specific, medicines

MAZE study shows inadequate use of migraine-specific medicines

Article | 13 September 2004

Print This

According to the results of the fourth phase of the MAZE (Migraine andZolmitriptan Evaluation) survey presented at the European Federation ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in